Ocular Drug Delivery Technology Market Size to Reach a Valuation of USD 30.2 billion by 2034, advancing at an 5.7% CAGR | Exclusive Report by Transparency Market Research
September 23, 2024 11:01 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research, Inc. , Sept. 23, 2024 (GLOBE NEWSWIRE) -- The ocular drug delivery technology industry (Industrie für...
Hyperhidrosis Treatment Market to Surpass USD 1.71 billion by 2027, Garnering 4.0% CAGR Says, Transparency Market Research
September 25, 2023 09:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The hyperhidrosis treatment market was estimated to have acquired US$ 1.2 billion in...
Vyteris and Zealand Pharma Announce Agreement on Active Transdermal Patch for Peptide Drugs
April 14, 2009 08:00 ET
|
Vyteris, Inc.
FAIR LAWN, NJ--(Marketwire - April 14, 2009) - Vyteris, Inc. (OTCBB: VYTR), developer of the
first FDA-approved active transdermal drug delivery system and a leader in
active transdermal drug...